DK73193D0 - Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner - Google Patents
Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanonerInfo
- Publication number
- DK73193D0 DK73193D0 DK93731A DK73193A DK73193D0 DK 73193 D0 DK73193 D0 DK 73193D0 DK 93731 A DK93731 A DK 93731A DK 73193 A DK73193 A DK 73193A DK 73193 D0 DK73193 D0 DK 73193D0
- Authority
- DK
- Denmark
- Prior art keywords
- phenylethylpyridinyl
- methanones
- piperidinyl
- substituted
- cyclohepta
- Prior art date
Links
- -1 4-PIPERIDINYL Chemical class 0.000 title 2
- OZVMEJXYSDZMDV-UHFFFAOYSA-N 11h-benzo[1,2]cyclohepta[3,4-b]pyridine Chemical class C1=CC2=NC=CC=C2CC2=CC=CC=C21 OZVMEJXYSDZMDV-UHFFFAOYSA-N 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/925,342 US4826853A (en) | 1986-10-31 | 1986-10-31 | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK73193D0 true DK73193D0 (da) | 1993-06-21 |
| DK73193A DK73193A (da) | 1993-06-21 |
Family
ID=25451584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK073193A DK73193A (da) | 1986-10-31 | 1993-06-21 | Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4826853A (da) |
| EP (3) | EP0330673A1 (da) |
| JP (1) | JPH0678316B2 (da) |
| KR (1) | KR930002489B1 (da) |
| AT (1) | ATE116310T1 (da) |
| AU (1) | AU604285B2 (da) |
| CA (2) | CA1305147C (da) |
| CS (1) | CS414391A3 (da) |
| DE (1) | DE3750929T2 (da) |
| DK (1) | DK73193A (da) |
| ES (1) | ES2068179T3 (da) |
| FI (1) | FI96768C (da) |
| HK (1) | HK186396A (da) |
| IE (1) | IE65174B1 (da) |
| IL (1) | IL84310A0 (da) |
| MY (1) | MY102986A (da) |
| NZ (1) | NZ222347A (da) |
| OA (1) | OA09546A (da) |
| PH (1) | PH26184A (da) |
| SG (1) | SG44597A1 (da) |
| WO (1) | WO1988003138A1 (da) |
| ZA (1) | ZA878128B (da) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3007193A (en) * | 1959-01-12 | 1961-11-07 | Nat Glass Company Inc | Adjustable hinge |
| US4804666A (en) * | 1985-08-14 | 1989-02-14 | Schering Corporation | Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines |
| US5438062A (en) * | 1986-10-31 | 1995-08-01 | Schering Corporation | Benzo(5,6)cycloheptapyridines, compositions and methods of use |
| US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| US5665726A (en) * | 1986-10-31 | 1997-09-09 | Schering Corporation | Benzo[5,6]cycloheptapyridines, compositions and methods of use |
| MY106964A (en) * | 1988-04-28 | 1995-08-30 | Schering Corp | Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents. |
| JPH0678315B2 (ja) * | 1988-04-28 | 1994-10-05 | シェリング・コーポレーション | 新規なベンゾピリド‐ピペリジン、ピペリジリデンおよびピペラジン化合物、組成物、製造法および利用法 |
| US4863931A (en) * | 1988-09-15 | 1989-09-05 | Schering Corporation | Antihistaminic fluoro substituted benzocycloheptapyridines |
| ES2012297A6 (es) * | 1989-04-10 | 1990-03-01 | Espnola De Especialidades Farm | Procedimiento para la obtencion de nuevos derivados imidazolicos diclorados con actividad antifungica. |
| US5095022A (en) * | 1989-07-04 | 1992-03-10 | Hokuriku Pharmaceutical Co., Ltd. | Piperidine derivatives and pharmaceutical compositions comprising the same |
| NZ238629A (en) * | 1990-06-22 | 1993-09-27 | Schering Corp | Bis-benzo- or benzopyrido-cyclohepta (where z is c, o, s or n) piperidine, piperidylidene or piperazine compounds, medicaments and methods of preparation |
| US5416087A (en) * | 1990-10-10 | 1995-05-16 | Wong; Jesse K. | Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
| ATE122673T1 (de) * | 1990-10-10 | 1995-06-15 | Schering Corp | Pyridin- und pyridin-n-oxid-derivate von diarylmethyl- piperidinen oder piperazinen, deren zusammensetzungen und anwendung. |
| EP0552292B1 (en) * | 1990-10-10 | 1995-06-21 | Schering Corporation | Substituted imidazobenzazepines and imidazopyridoazepines |
| KR920014799A (ko) * | 1991-01-18 | 1992-08-25 | 나오가따 다이도 | 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제 |
| AU2028892A (en) * | 1991-05-23 | 1992-12-30 | Schering Corporation | Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
| EP0524784A1 (en) * | 1991-07-23 | 1993-01-27 | Schering Corporation | Benzopyrido piperidylidene compounds as PAF antagonists |
| JP2974529B2 (ja) * | 1992-02-20 | 1999-11-10 | 北陸製薬株式会社 | 両性型三環系化合物 |
| DE69303605T2 (de) * | 1992-03-27 | 1997-01-23 | Schering Corp | Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung |
| ATE153336T1 (de) * | 1992-03-27 | 1997-06-15 | Schering Corp | Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung |
| WO1993023400A1 (en) * | 1992-05-19 | 1993-11-25 | Schering Corporation | Pentacyclic antihistamines |
| ES2042421B1 (es) * | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
| EP0708776B1 (en) * | 1993-07-13 | 2001-01-03 | Janssen Pharmaceutica N.V. | Antiallergic imidazoazepines |
| JP2875393B2 (ja) * | 1993-10-15 | 1999-03-31 | シェーリング コーポレイション | Ｇ−タンパク質機能の阻害および増殖性疾患の治療に有用な三環式カルバメート化合物 |
| US5661152A (en) * | 1993-10-15 | 1997-08-26 | Schering Corporation | Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| US5721236A (en) | 1993-10-15 | 1998-02-24 | Schering Corporation | Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| US6075025A (en) | 1993-10-15 | 2000-06-13 | Schering Corporation | Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US6365588B1 (en) | 1993-10-15 | 2002-04-02 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| ES2087818B1 (es) * | 1993-11-24 | 1997-03-16 | Uriach & Cia Sa J | 8-cloro-11-(1-((5-metil-3-piridil)metil)-4-piperidiliden)-6,11-dihidro-5h-benzo-(5,6)cicloheptal(1,2-b)piridina, fumarato. |
| US5574173A (en) * | 1993-12-06 | 1996-11-12 | Schering Corporation | Tricyclic derivatives, compositions and methods of use |
| US5464840A (en) * | 1993-12-06 | 1995-11-07 | Schering Corporation | Tricyclic derivatives, compositions and methods of use |
| US5538986A (en) * | 1993-12-06 | 1996-07-23 | Schering Corporation | Tricyclic derivatives, compositions and methods of use |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| ES2080699B1 (es) * | 1994-07-27 | 1996-10-16 | Farmahispania S A | Nuevos derivados de 2-(1-etoxicarbonil-4-piperidiliden)metil)piridina y un procedimiento para su obtencion. |
| ES2080700B1 (es) * | 1994-07-27 | 1996-10-16 | Farmihispania S A | Nuevo procedimiento para la obtencion de loratadina. |
| ES2087026B1 (es) * | 1994-07-28 | 1997-03-16 | Uriach & Cia Sa J | Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina. |
| US5461057A (en) * | 1994-09-08 | 1995-10-24 | Schering Corporation | Hydro-ethano-indeno-pyridines |
| US5684013A (en) * | 1995-03-24 | 1997-11-04 | Schering Corporation | Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| US5700806A (en) * | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5712280A (en) * | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5801175A (en) | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| US5891872A (en) * | 1995-04-07 | 1999-04-06 | Schering Corporation | Tricyclic compounds |
| US5874442A (en) * | 1995-12-22 | 1999-02-23 | Schering-Plough Corporation | Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
| PE92098A1 (es) * | 1996-07-31 | 1998-12-31 | Schering Corp | N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo |
| CN1047774C (zh) * | 1996-09-10 | 1999-12-29 | 上海华联制药有限公司 | 氮杂二苯并环庚烯酮类化合物的制备方法 |
| US5861395A (en) * | 1996-09-13 | 1999-01-19 | Schering Corporation | Compounds useful for inhibition of farnesyl proteins transferase |
| US6030982A (en) | 1996-09-13 | 2000-02-29 | Schering Corporationm | Compounds useful for inhibition of farnesyl protein transferase |
| US6040305A (en) * | 1996-09-13 | 2000-03-21 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US5985879A (en) * | 1996-09-13 | 1999-11-16 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| DE69732120T2 (de) * | 1996-09-13 | 2005-12-08 | Schering Corp. | Trizyklische inhibitoren der farnesyl protein transferase |
| US5994364A (en) | 1996-09-13 | 1999-11-30 | Schering Corporation | Tricyclic antitumor farnesyl protein transferase inhibitors |
| US5958890A (en) * | 1996-09-13 | 1999-09-28 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| ES2229340T3 (es) * | 1996-09-13 | 2005-04-16 | Schering Corporation | Compuestos triciclicos antitumorales, inhibidores de farnesil-proteina-tranferasa. |
| CZ84299A3 (cs) * | 1996-09-13 | 1999-09-15 | Schering Corporation | Sloučeniny vhodné pro inhibici farnesylproteintransferasy |
| US6071907A (en) * | 1996-09-13 | 2000-06-06 | Schering Corporation | Tricyclic compounds useful as FPT inhibitors |
| TR199901275T2 (xx) * | 1996-09-13 | 1999-09-21 | Schering Corporation | Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler. |
| US5945429A (en) * | 1996-09-13 | 1999-08-31 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US6130229A (en) * | 1996-10-09 | 2000-10-10 | Schering Corporation | Tricyclic compounds having activity as RAS-FPT inhibitors |
| US6689789B2 (en) * | 1997-06-17 | 2004-02-10 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US6576639B1 (en) | 1997-06-17 | 2003-06-10 | Schering Corporation | Compounds for the inhibition of farnesyl protein transferase |
| US5925639A (en) * | 1997-06-17 | 1999-07-20 | Schering Corporation | Keto amide derivatives useful as farnesyl protein transferase inhibitors |
| US6228865B1 (en) | 1997-06-17 | 2001-05-08 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US6239140B1 (en) | 1997-06-17 | 2001-05-29 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US5945430A (en) * | 1997-06-17 | 1999-08-31 | Schering Corporation | Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase |
| ES2196566T3 (es) * | 1997-06-17 | 2003-12-16 | Schering Corp | Nuevos compuestos triciclicos de aminooxiamida inhibidores de la farnesil-proteina-transferasa. |
| IL133392A0 (en) * | 1997-06-17 | 2001-04-30 | Schering Corp | Benzo (5, 6) cyclohepta (1, 2b) pyridine derivatives useful for inhibition of farnesyl protein transferase |
| US6051582A (en) * | 1997-06-17 | 2000-04-18 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US6211193B1 (en) | 1997-06-17 | 2001-04-03 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| WO1998057945A1 (en) * | 1997-06-17 | 1998-12-23 | Schering Corporation | Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| NZ501617A (en) * | 1997-06-17 | 2001-09-28 | Schering Corp | 4-(5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine derivatives useful for inhibition of farnesyl protein transferase |
| US6218401B1 (en) | 1997-06-17 | 2001-04-17 | Schering Corporation | Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| TR200000114T2 (tr) * | 1997-06-17 | 2000-08-21 | Schering Corporation | Farnesil protein transferazı'nın önlenmesine mahsus benzo(5,6)siklohepta(1,2-B)piridin türevleri. |
| US6159984A (en) * | 1997-06-17 | 2000-12-12 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US5925648A (en) * | 1997-07-29 | 1999-07-20 | Schering Corporation | Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| PE20001566A1 (es) | 1999-03-26 | 2001-02-05 | Ucb Sa | Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas |
| US6686502B1 (en) | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| DE60217934T2 (de) * | 2002-09-24 | 2007-05-24 | Morepen Laboratories Ltd. | Verfahren zur herstellung von desloratadin |
| WO2004080461A2 (en) * | 2003-03-12 | 2004-09-23 | TEVA Gyógyszergyár Részvénytársaság | Stable pharmaceutical compositions of desloratadine |
| RU2408584C2 (ru) | 2005-06-23 | 2011-01-10 | Мерк Шарп Энд Домэ Корп. | Ингибиторы тирозинкиназы |
| US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
| AU2006306496A1 (en) | 2005-10-21 | 2007-05-03 | Merck Sharp & Dohme Corp. | Tyrosine kinase inhibitors |
| TW200813021A (en) | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| US20080287481A1 (en) * | 2006-09-08 | 2008-11-20 | Mayur Devjibhai Khunt | Process for the preparation of desloratadine polymorph mixtures |
| CN103113348B (zh) * | 2013-02-18 | 2015-03-25 | 扬子江药业集团江苏海慈生物药业有限公司 | 枸地氯雷他定的假多晶型及其制备方法 |
| CN110845473B (zh) * | 2019-10-08 | 2023-04-07 | 深圳市南山区人民医院 | 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-乙酸乙酯及其用途 |
| CN110818684B (zh) * | 2019-10-08 | 2023-04-07 | 深圳市南山区人民医院 | 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-SH及其用途 |
| CN110818685A (zh) * | 2019-10-08 | 2020-02-21 | 深圳市南山区人民医院 | 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-异己基及其用途 |
| AU2020372682A1 (en) | 2019-10-31 | 2022-06-09 | Jd Bioscience Inc. | Tricyclic compound and pharmaceutical use thereof |
| CN115385892A (zh) * | 2021-10-28 | 2022-11-25 | 天津市昕晨投资发展有限公司 | 地氯雷他定衍生物、其制备方法及其用途 |
| CN115141229B (zh) * | 2022-07-21 | 2023-12-12 | 华创合成制药股份有限公司 | 抗组胺类化合物及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3419565A (en) * | 1963-04-24 | 1968-12-31 | Schering Corp | Aza-dibenzocycloheptenes |
| NL132137C (da) * | 1963-04-24 | |||
| US3409621A (en) * | 1966-04-01 | 1968-11-05 | Schering Corp | Piperazino-aza-dibenzo-[a, d]-cycloheptenes |
| US3717647A (en) * | 1971-04-09 | 1973-02-20 | Schering Corp | Alpha-nicotinoyl phenylacetonitriles |
| DK401476A (da) * | 1975-09-15 | 1977-03-16 | Sandoz Ag | Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser |
| US4335036A (en) | 1980-05-30 | 1982-06-15 | E. I. Du Pont De Nemours And Company | Plasticized polyvinyl butyral employing propylene oxide oligomers |
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| US4355036A (en) * | 1980-06-19 | 1982-10-19 | Schering Corporation | Tricyclic-substituted piperidine antihistamines |
| WO1985003707A1 (en) * | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| EP0208855B1 (en) * | 1985-05-13 | 1991-03-06 | Schering Corporation | process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions |
| US4804666A (en) * | 1985-08-14 | 1989-02-14 | Schering Corporation | Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines |
-
1986
- 1986-10-31 US US06/925,342 patent/US4826853A/en not_active Expired - Fee Related
-
1987
- 1987-10-29 EP EP87908033A patent/EP0330673A1/en active Pending
- 1987-10-29 KR KR1019880700738A patent/KR930002489B1/ko not_active Expired - Fee Related
- 1987-10-29 DE DE3750929T patent/DE3750929T2/de not_active Expired - Fee Related
- 1987-10-29 NZ NZ222347A patent/NZ222347A/xx unknown
- 1987-10-29 SG SG1996003470A patent/SG44597A1/en unknown
- 1987-10-29 WO PCT/US1987/002777 patent/WO1988003138A1/en not_active Ceased
- 1987-10-29 IL IL84310A patent/IL84310A0/xx not_active IP Right Cessation
- 1987-10-29 AU AU83362/87A patent/AU604285B2/en not_active Ceased
- 1987-10-29 EP EP87115890A patent/EP0270818B1/en not_active Expired - Lifetime
- 1987-10-29 EP EP94108677A patent/EP0685476A1/en not_active Withdrawn
- 1987-10-29 ZA ZA878128A patent/ZA878128B/xx unknown
- 1987-10-29 MY MYPI87002990A patent/MY102986A/en unknown
- 1987-10-29 AT AT87115890T patent/ATE116310T1/de not_active IP Right Cessation
- 1987-10-29 ES ES87115890T patent/ES2068179T3/es not_active Expired - Lifetime
- 1987-10-29 IE IE291387A patent/IE65174B1/en not_active IP Right Cessation
- 1987-10-29 JP JP63500276A patent/JPH0678316B2/ja not_active Expired - Lifetime
- 1987-10-29 PH PH36002A patent/PH26184A/en unknown
- 1987-10-30 CA CA000550729A patent/CA1305147C/en not_active Expired - Lifetime
-
1989
- 1989-04-17 FI FI891806A patent/FI96768C/fi not_active IP Right Cessation
- 1989-04-28 OA OA59569A patent/OA09546A/en unknown
-
1991
- 1991-12-30 CS CS914143A patent/CS414391A3/cs unknown
-
1992
- 1992-02-07 CA CA000616309A patent/CA1321589C/en not_active Expired - Fee Related
-
1993
- 1993-06-21 DK DK073193A patent/DK73193A/da not_active Application Discontinuation
-
1996
- 1996-10-03 HK HK186396A patent/HK186396A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PH26184A (en) | 1992-03-18 |
| MY102986A (en) | 1993-03-31 |
| IE65174B1 (en) | 1995-10-04 |
| DE3750929D1 (de) | 1995-02-09 |
| KR880701716A (ko) | 1988-11-04 |
| US4826853A (en) | 1989-05-02 |
| JPH02500910A (ja) | 1990-03-29 |
| FI891806A0 (fi) | 1989-04-17 |
| JPH0678316B2 (ja) | 1994-10-05 |
| IE872913L (en) | 1988-04-30 |
| ATE116310T1 (de) | 1995-01-15 |
| KR930002489B1 (ko) | 1993-04-02 |
| EP0685476A1 (en) | 1995-12-06 |
| EP0330673A1 (en) | 1989-09-06 |
| EP0270818B1 (en) | 1994-12-28 |
| OA09546A (en) | 1993-01-31 |
| AU604285B2 (en) | 1990-12-13 |
| FI96768C (fi) | 1996-08-26 |
| EP0270818A1 (en) | 1988-06-15 |
| AU8336287A (en) | 1988-05-25 |
| CA1305147C (en) | 1992-07-14 |
| SG44597A1 (en) | 1997-12-19 |
| ZA878128B (en) | 1988-04-29 |
| FI96768B (fi) | 1996-05-15 |
| FI891806L (fi) | 1989-04-17 |
| WO1988003138A1 (en) | 1988-05-05 |
| DK73193A (da) | 1993-06-21 |
| DE3750929T2 (de) | 1995-06-01 |
| CA1321589C (en) | 1993-08-24 |
| IL84310A0 (en) | 1988-03-31 |
| CS414391A3 (en) | 1992-09-16 |
| ES2068179T3 (es) | 1995-04-16 |
| NZ222347A (en) | 1990-03-27 |
| HK186396A (en) | 1996-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK73193A (da) | Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner | |
| US5151423B1 (en) | Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use | |
| FI880941A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi | |
| NO883506L (no) | Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater. | |
| NO880452D0 (no) | Fremgangsmaate for fremstilling av nye polyaminderivater. | |
| NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| IE872839L (en) | Benzocycloheptapyridines | |
| NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
| NO172490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| FI884660L (fi) | Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi | |
| FI893345A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsinonijohdannaisten valmistamiseksi | |
| ES546866A0 (es) | Procedimiento de preparar derivados antihipertensivos | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| FI893121L (fi) | Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi | |
| NO880922D0 (no) | Fremgangsmaate for fremstilling av farmakologisk aktive benzodioksolderivater. | |
| FI906246L (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 1-(4-fluorifenyyli)-2-(1-piperidyyli)etanonijohdannaisten valmistamiseksi | |
| FI910816L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi | |
| NO881709D0 (no) | Fremgangsmaate ved fremstilling av nye dihydropyridinderivater. | |
| NO911665D0 (no) | Fremgangsmaate for fremstilling av nye nojirimycinderivater | |
| NO922254D0 (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater | |
| NO922253L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| AHB | Application shelved due to non-payment |